A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
Clinical trial NCT07301229 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07301229
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2028-02-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.